Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pacific Horizon: Encouraging Mutations in the Venture Model

Dec 01 2007

• By Chris Morrison

Related Content

The New World for New Drug Approvals: Evolution in Strategies for Getting FDA Drug Approvals

Nov 01 2007

Alzheimer's R&D: Tweaking Venture's Risk-Reward Ratio

Sep 01 2007

Getting the Bugs Out of Antibiotic R&D: Commercial Implications of a Higher Regulatory Hurdle

Jun 01 2007

Hep C Development Dilemma: Big Money Now or Bigger Money Later?

Dec 01 2005

Related Companies

Koronis Pharmaceuticals, Inc.

Illumigen Biosciences Inc.

Cubist Pharmaceuticals, Inc.

ViaCyte, Inc.

TransMolecular, Inc.

Human Genome Sciences, Inc.

Novartis AG

Johnson & Johnson

Vertex Pharmaceuticals Incorporated

Roche Holding AG

InterMune, Inc.

Wyeth

Altiris Therapeutics, Inc.

Allergan plc

Presidio Pharmaceuticals, Inc.

Merck & Co., Inc.

GSK plc

Bristol Myers Squibb Company

Abbott

Gilead Sciences, Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window